mifepristone

On the fourth anniversary of the Dobbs v. Jackson Women’s Health Organization decision by the U.S. Supreme Court, the U.S. bishops and pro-life leaders pointed to abortion pills as among …

WASHINGTON (OSV News) — The Trump administration signed a memorandum of understanding, or MOU, with Iranian officials, a tentative framework to end the war in Iran, but uncertainty remained about an …

The U.S. Supreme Court on May 14 blocked an appeals court ruling that sought to pause a federal policy permitting mifepristone, sometimes called the abortion pill, to be dispensed through …

President Donald Trump on May 12 confirmed that Marty Makary, the embattled FDA commissioner criticized by pro-life advocates and others, will leave his post.

The same week, Chief Justice John Roberts lamented public perception of the high court as “political actors.”

The head of the bishops’ pro-life committee has written to Trump administration officials his concerns about the status of their mifepristone safety review.

An appeals court on May 1 temporarily blocked ‌a federal policy permitting mifepristone, sometimes called the abortion pill, to be dispensed through the mail.

The Supreme Court ruled that Louisiana’s congressional map creating a second majority-Black congressional district was “an unconstitutional racial gerrymander.”

States and jurisdictions are not required to report their abortion data to the Centers for Disease Control’s Abortion Surveillance System.

The state lawsuits seek to end the FDA policy implemented during the Biden administration permitting mifepristone to be distributed by mail.